FGF19 and obesity due to melanocortin 4 receptor deficiency: Administering FGF19 into a liver-specific Klb-deficient mouse with diet-induced obesity can still significantly reduce body weight accompanied with lower food intake, reduced serum plasma concentration, and hepatic triglyceride levels [172,173].